Orexin administration to mice that underwent chronic stress produces bimodal effects on emotion-related behaviors

Regulatory Peptides

Volumn 194-195, Issue , 2014, Pages 16-22

  Chung, Hye Seung ^a   Kim, Jae Gon ^a   Kim, Jae Won ^a   Kim, Hyung Wook ^b   Yoon, Bong June ^a  

^a Korea University   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Anxiety; Orexin; Social defeat stress; Stress susceptibility

Indexed keywords

MESSENGER RNA; OREXIN; OREXIN A; OREXIN B; OREXIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; CHRONIC STRESS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFECT; EMOTIONALITY; IMMOBILIZATION STRESS; LONG TERM EXPOSURE; MALE; MONOTHERAPY; MOUSE; NONHUMAN; SOCIAL INTERACTION; SOCIAL STRESS; STRIA TERMINALIS; TRANQUILIZING ACTIVITY; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; EMOTION; MENTAL STRESS; PATHOPHYSIOLOGY; SEPTUM NUCLEUS; THALAMUS;

ANIMALIA; MUS;

ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DEPRESSION; DISEASE MODELS, ANIMAL; EMOTIONS; MALE; MICE; MICE, INBRED C57BL; OREXINS; SEPTAL NUCLEI; STRESS, PSYCHOLOGICAL; THALAMUS;

EID: 84921343968     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2014.11.003     Document Type: Article

References (36)

1. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nature reviews. Neuroscience 2007, 8:171-181.
2. Johnson P.L., Molosh A., Fitz S.D., Truitt W.A., Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012, 198:133-161.
3. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827:243-260.
4. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
5. Sakurai T., Nagata R., Yamanaka A., Kawamura H., Tsujino N., Muraki Y., Kageyama H., Kunita S., Takahashi S., Goto K., Koyama Y., Shioda S., Yanagisawa M. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46:297-308.
6. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006, 494:845-861.
7. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
8. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
9. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6:991-997.
10. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424.
11. Sakurai T. Orexin: a link between energy homeostasis and adaptive behaviour. Curr Opin Clin Nutr Metab Care 2003, 6:353-360.
12. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
13. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
14. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 2008, 28:3071-3075.
15. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., Traskman-Bendz L., Goddard A.W., Brundin L., Shekhar A. A key role for orexin in panic anxiety. Nat Med 2010, 16:111-115.
16. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 2005, 1044:116-121.
17. Lungwitz E.A., Molosh A., Johnson P.L., Harvey B.P., Dirks R.C., Dietrich A., Minick P., Shekhar A., Truitt W.A. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol Behav 2012, 107:726-732.
18. Avolio E., Alo R., Carelli A., Canonaco M. Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster. Behav Brain Res 2011, 218:288-295.
19. Russo S.J., Murrough J.W., Han M.H., Charney D.S., Nestler E.J. Neurobiology of resilience. Nat Neurosci 2012, 15:1475-1484.
20. Kim J.G., Jung H.S., Kim K.J., Min S.S., Yoon B.J. Basal blood corticosterone level is correlated with susceptibility to chronic restraint stress in mice. Neurosci Lett 2013, 555:137-142.
21. Kim J.W., Ahn H.S., Baik J.H., Yoon B.J. Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice. J Psychopharmacol 2013, 27:171-180.
22. Paxinos G. The mouse brain in stereotaxic coordinates 2004, Gulf Professional Publishing.
23. Schmitt O., Usunoff K.G., Lazarov N.E., Itzev D.E., Eipert P., Rolfs A., Wree A. Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct 2012, 217:233-256.
24. Roman C.W., Lezak K.R., Kocho-Schellenberg M., Garret M.A., Braas K., May V., Hammack S.E. Excitotoxic lesions of the bed nucleus of the stria terminalis (BNST) attenuate the effects of repeated stress on weight gain: evidence for the recruitment of BNST activity by repeated, but not acute, stress. Behav Brain Res 2012, 227:300-304.
25. Brutus M., Zuabi S., Siegel A. Effects of D-Ala2-Met5-enkephalinamide microinjections placed into the bed nucleus of the stria terminalis upon affective defense behavior in the cat. Brain Res 1988, 473:147-152.
26. Bonaz B., Rivest S. Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am J Physiol 1998, 275:R1438-R1449.
27. Kim K.S., Han P.L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J Neurosci Res 2006, 83:497-507.
28. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000, 270:318-323.
29. Scott M.M., Marcus J.N., Pettersen A., Birnbaum S.G., Mochizuki T., Scammell T.E., Nestler E.J., Elmquist J.K., Lutter M. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res 2011, 222:289-294.
30. Arendt D.H., Hassell J., Li H., Achua J.K., Guarnieri D.J., Dileone R.J., Ronan P.J., Summers C.H. Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala. Psychoneuroendocrinology 2014, 40:17-26.
31. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton Neurosci 2011, 161:20-27.
32. Zhang W., Zhang N., Sakurai T., Kuwaki T. Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res 2009, 1262:25-37.
33. Conrad K.L., Davis A.R., Silberman Y., Sheffler D.J., Shields A.D., Saleh S.A., Sen N., Matthies H.J., Javitch J.A., Lindsley C.W., Winder D.G. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 2012, 37:2253-2266.
34. Shin H.S., Cho H.S., Sung K.W., Yoon B.J. Orexin-A increases cell surface expression of AMPA receptors in the striatum. Biochem Biophys Res Commun 2009, 378:409-413.
35. McElligott Z.A., Klug J.R., Nobis W.P., Patel S., Grueter B.A., Kash T.L., Winder D.G. Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. Proc Natl Acad Sci U S A 2010, 107:2271-2276.
36. Weinhold S.L., Seeck-Hirschner M., Nowak A., Hallschmid M., Goder R., Baier P.C. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res 2014, 262:8-13.